ActHIB® Haemophilus Influenzae Type b Vaccine (Hib) Children 2 Months to 5 Years of Age 10 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL by Sanofi Pasteur (Aventis) ID 49281-0545-03

200-7-5455BX
      
Stock Est. Shipping Date: 30th April 2025

ActHIB® Haemophilus Influenzae Type b Vaccine (Hib) Children 2 Months to 5 Years of Age 10 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Sold by: BX OF 5

 Reviews
Better together

  • Total: $0.00

Sanofi Pasteur #545-03 ActHIB® Haemophilus Influenzae Type b Vaccine (Hib) Children 2 Months to 5 Years of Age 10 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL ACTHIB , SDV 10MCG/0.5ML 0.05ML W/DILUENT (5/BX) Features ActHIB is a vaccine indicated for the prevention of invasive disease caused by Haemophilus influenzae type b ActHIB vaccine is approved for use as a four dose series in infants and children 2 months through 5 years of age Manufacturer # 545-03 Brand ActHIB® Manufacturer Sanofi Pasteur Country of Origin France Application Haemophilus Influenzae Type b Vaccine (Hib) Container Type Single Dose Vial Dosage Form Injection Generic Drug Code 99298 Generic Drug Name Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), Preservative Free NDC Number 49281-0545-03 Product Dating Acceptable Dating: we will ship >= 180 days Storage Requirements Requires Refrigeration Strength 10 mcg / 0.5 mL Type Intramuscular UNSPSC Code 51201627 User Children 2 Months to 5 Years of Age Volume 0.5 mL
Size: 0.5ML
More Information
No recommended products at the moment.